Puma Biotechnology, Inc.PBYINASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank93
3Y CAGR-95.3%
Studio
Year-over-Year Change

Price-to-earnings ratio

3Y CAGR
-95.3%/yr
Annual compound
Percentile
P93
Near historical high
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthCompressed
PeriodValueYoY Change
20259.56+95.2%
20244.90-48.2%
20239.45-100.0%
202294486.57+2227693.3%
2021-4.24+37.3%
2020-6.77-50.8%
2019-4.49+34.0%
2018-6.80+46.0%
2017-12.58-239.8%
2016-3.70-